Business
ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news
It looks set to be another positive day of trade for the S&P/ASX 200 Index (ASX: XJO) on Tuesday after a third COVID-19 vaccine candidate was shown to be effective.
At the time of writing, SPI futures are pointing to the ASX opening the day 31 points or 0.5% higher this morning.
What is the new vaccine candidate?
Overnight British pharmaceutical giant AstraZeneca revealed that data from an interim analysis of clinical trials showed that its vaccine, AZD1222, had an average efficacy of 70% in protecting against COVID-19.
This follows recent updates by both Pfizer and Moderna which showed that their vaccines are 95% effective against the virus.
While 70% might not sound amazing, it is worth noting that the AstraZeneca vaccine,…
-
General12 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News18 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General15 hours agoTrump mulling whether to fire US Fed chair Powell
-
Noosa News18 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game